Cocrystal Pharma Inc. (NASDAQ:COCP) Stock is Soaring, Here is Why

Cocrystal Pharma Inc. (NASDAQ:COCP) Stock is Soaring, Here is Why


The Cocrystal Pharma Inc. (COCP) shares are trading at higher $2.22 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $2.95 and the low is $0.39. Over the last 52 weeks, COCP is down -24.75% while the S&P 500 is up 0.81%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, COCP reported a profit of $2.42 million. Cocrystal Pharma Inc. also saw revenues increase to $0.46 million. In addition, COCP has free cash flow of -$2.28 million as of 03-2020. The company’s EBITDA came in at -$1.89 million which compares well with its peers.

COCP Return on Equity (ROE) is -101.50%, and its Return on Assets is -96.70%. All told, it is clear that, COCP needs to be on your watchlist.

Find out when COCP reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. COCP has a short ratio of 0.04 and outstanding shares of 41.66M.

Company Outlook

COCP has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 4.78 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.57. Cocrystal Pharma Inc. COCP also noted assets of $42.84 million at the end of the last quarter. Investors should also keep an eye on sector updates as COCP has historically followed its peers on positive news.

All told, Cocrystal Pharma Inc. COCP has strung together solid data and demonstrated underlying fundamentals. At its current valuation, COCP represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Cocrystal Pharma Inc. COCP is now commanding a market cap of 107.18M and a float of 32.23M. COCP is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of COCP stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in COCP, either long or short, and we have not been compensated for this article.